Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine).
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.
Lodonal/LDN
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis.
American Academy of Neurology Annual Meeting
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy.
Patients with migraine do not have MRI-visible cortical lesions.
Autoimmune myelopathies.
The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Long-term effects of dalfampridine in patients with multiple sclerosis.
Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis.
The impact of environmental infections (parasites) on MS activity.
Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse.
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.

Pages